CA Patent

CA2892811C — Allopregnanolone and a sulfobutylether-b-cyclodextrin salt for the treatment of post-partum depression

Assigned to University of California San Diego UCSD · Expires 2025-07-22 · 1y expired

What this patent protects

The present invention relates to methods of preventing, inhibiting, delaying, and/or mitigating seizures by administration of a steroid, e.g., a neurosteroid, e.g., allopregnanolone.

USPTO Abstract

The present invention relates to methods of preventing, inhibiting, delaying, and/or mitigating seizures by administration of a steroid, e.g., a neurosteroid, e.g., allopregnanolone.

Drugs covered by this patent

Patent Metadata

Patent number
CA2892811C
Jurisdiction
CA
Classification
—
Expires
2025-07-22
Drug substance claim
No
Drug product claim
No
Assignee
University of California San Diego UCSD
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.